Skip to content
Catalyst

fucoxanthinFinding

Fucoxanthin has no detected effect on alanine aminotransferase

no difference foundInsufficient evidenceFinding

01 · The sentence it was drawn from

“No significant differences were present in liver triglyceride and total cholesterol, hepatic fat accumulation, and serum alanine aminotransferase levels between control and FCX-fed mice regardless of whether they were on an HFC or HFS diet.”
Quoted verbatim from Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.
This finding among the 73 findings on its endpoint

fucoxanthin

Alanine aminotransferase

no difference found

Who
C57BL/6J mice, pooled across HFC (high-fat/high-sucrose/high-cholesterol) and HFS (high-fat/high-sucrose) diet-induced obesity models, FCX-supplemented diet vs same diet without FCX
Dose studied
0.015% or 0.03% w/w FCX in HFC diet, 12 weeks; 0.01% w/w FCX in HFS diet, 8 weeks

Insufficient evidencePMID 35684079 · 2022

02 · The study

Study
animal · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PA4WVE9B4V9C0T4N36VTE0